Clinical trial
Collection of Plasma Samples Using Sodium Heparin From Subjects Undergoing Intravenous Busulfan Treatment
NCT05711732 is registered in ClinicalTrials.gov with Saladax Biomedical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Collection of Plasma Samples Using Sodium Heparin From Subjects Undergoing Intravenous Busulfan Treatment
- Lead sponsor
- Saladax Biomedical, Inc.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 8, 2024
- Completion date
- April 30, 2027
- Enrollment
- 150 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
subjects treated with busulfan